Business News

Advanco Acquires Vantage Consulting Group

June 15, 2023

Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

Pistoia Alliance and Matador Japan Collaborate to Accelerate Research

June 15, 2023

The collaboration between the Pistoia Alliance and Matador Japan will work to accelerate research and promote access to a global pharmaceutical ecosystem.

Mendus and NorthXBiologics Enter Cell Therapy Manufacturing Alliance

June 15, 2023

Mendus and NorthX Biologics will work to develop and commercialize Mendus’ lead asset, vididencel, an allogeneic dendritic cell vaccine.

AstraZeneca and Quell Therapeutics Strike Cell Therapy Development Deal

June 14, 2023

The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

mRNA Global Alliance Tests the Waters at BIO

June 12, 2023

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.

Biosimilar CDMO Capacity Increased in Samsung Biologics – Pfizer’s New Arrangement

June 08, 2023

The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

Merck Files Lawsuit Against US Government

June 08, 2023

The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

Sartorius and Waters Expand Analytics Collaboration

June 08, 2023

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

Aragen Life Sciences and FAR Biotech Enter Neurodegeneration Collaboration

May 30, 2023

Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.

Novartis Purchases Cystinosis Gene Therapy from AVROBIO

May 30, 2023

The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.